Metropolitan Government of Nashville-Davidson (balance), TN, United States

Meharry Medical College

www.mmc.edu
Metropolitan Government of Nashville-Davidson (balance), TN, United States

Meharry Medical College, located in Nashville, Tennessee, United States, is a graduate and professional institution affiliated with the United Methodist Church whose mission is to educate healthcare professionals and scientists. Founded in 1876 as the Medical Department of Central Tennessee College, it was the first medical school in the South for African Americans, though not the first medical school for African-Americans in the nation; the Howard University College of Medicine was chartered in 1868, for example.Meharry Medical College was chartered separately in 1915. It is currently the largest private historically black institution in the United States solely dedicated to educating healthcare professionals and scientists.Meharry Medical College includes a medical school, dental school, graduate school, and an allied health school. The degrees that Meharry offers include Doctor of Medicine , Doctor of Dental Surgery , Master of Science in Public Health , Master of Science , and Doctor of Philosophy degrees. Meharry is the second largest educator of African-American medical doctors and dentists in the United States. Also, it is the largest producer of African Americans with Masters in Public Health and Ph.D.s in biomedical science.Journal of Health Care for the Poor and Underserved is a public health journal owned by and edited at Meharry Medical College. Wikipedia.

SEARCH FILTERS
Time filter
Source Type

The International Association of HealthCare Professionals is pleased to welcome Dr. Teethena C. Cooper, MD, Anesthesiologist to their prestigious organization with her upcoming publication in The Leading Physicians of the World. Dr. Teethena C. Cooper is a highly trained and qualified physician with a vast expertise in all facets of her work. She has been in practice for more than seven years and is currently serving patients within Good Samaritan Hospital in Mount Vernon, Illinois. Dr. Cooper’s career in medicine began in 2009 when she graduated from Meharry Medical College in Nashville, Tennessee. Upon receiving her Medical Degree, she completed a residency at the University of Chicago. Dr. Cooper is certified by the American Board of Anesthesiology, and is a distinguished member of the Illinois Society of Anesthesiologists. She says that her success is thanks to her drive to serve and help the underprivileged in society, and when she is not working Dr. Cooper enjoys traveling to Australia and Europe, and particularly enjoys visiting Paris. Learn more about Dr. Cooper here: http://www.ssmhealthillinois.com/physicians/teethena-c-cooper-md and be sure to read her upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit http://www.findatopdoc.com


The International Association of HealthCare Professionals is pleased to welcome Dr. Teethena C. Cooper, MD, Anesthesiologist to their prestigious organization with her upcoming publication in The Leading Physicians of the World. Dr. Teethena C. Cooper is a highly trained and qualified physician with a vast expertise in all facets of her work. She has been in practice for more than seven years and is currently serving patients within Good Samaritan Hospital in Mount Vernon, Illinois. Dr. Cooper’s career in medicine began in 2009 when she graduated from Meharry Medical College in Nashville, Tennessee. Upon receiving her Medical Degree, she completed a residency at the University of Chicago Pritzker School of Medicine. Dr. Cooper is certified by the American Board of Anesthesiology, and is a distinguished member of the Illinois Society of Anesthesiologists. She credits her successful career in anesthesiology to God, her supportive family, and to the many patients whom she has had the honor to serve. Her passion is to provide the best care to all her patients, especially those who are are economically and socially disadvantaged. In her free time, Dr. Cooper enjoys traveling abroad to Australia and Europe, and particularly enjoys visiting Paris, France. Learn more about Dr. Cooper here: http://www.ssmhealthillinois.com/physicians/teethena-c-cooper-md and be sure to read her upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit http://www.findatopdoc.com


News Article | July 11, 2017
Site: www.prnewswire.com

Dr. Wright A. Jones, founder and medical director of Muse Plastic Surgery, had a very specific vision in mind when creating the practice. His aesthetic skill can be customized to meet the cosmetic goals and unique needs of his patients who travel from all over the world. Muse Plastic Surgery is based on the fundamentals of delivering superior surgical results without sacrificing high quality patient care. "The new name is a better reflection of our practice.  We remain steadfast to the tenets of safe medicine, but our philosophy has evolved to include a major emphasis on the artistic implications of each technique.  We are inspired by each patient to create something beautiful based on their individual characteristics." Dr. Jones is a native of Georgia with a passion for the field of plastic surgery that developed at a very early age, and has continued to shape and guide his educational trajectory. After receiving his undergraduate degree in Biology from Fort Valley State University, and his Medical Degree from Meharry Medical College, Dr. Jones went on to complete his Residency in General Surgery at the University of Nevada in Las Vegas, where he served as Chief Resident. Dr. Jones performed his Residency in Plastic and Reconstructive Surgery at the prestigious Emory University School of Medicine where he worked side by side with world-renowned plastic surgeons, honing his surgical skills while utilizing cutting edge reconstructive and plastic surgery techniques. Dr. Jones has a special interest in rhinoplasty, eyelid surgery and body contouring. For more information on Muse Plastic Surgery, visit www.WrightJonesPlasticSurgery.com


News Article | July 26, 2017
Site: www.eurekalert.org

ARLINGTON, Va., July 26, 2017--Edith Peterson Mitchell, MD, a leading researcher, medical oncologist and proponent of combined modality treatment, has been chosen as the 2017 American Society for Radiation Oncology (ASTRO) Honorary Member. Dr. Mitchell will receive this award, which is the highest honor ASTRO awards to distinguished cancer researchers and leaders in disciplines outside of radiation oncology, radiobiology or radiation physics, at ASTRO's 59th Annual Meeting in San Diego on Tuesday, September 26, 2017. "Dr. Edith Mitchell has been a longtime proponent of combined modality treatment--using chemotherapy and radiation therapy together in order to provide cancer patients with the best possible outcomes," says ASTRO Chair David C. Beyer, MD, FASTRO. "Our specialty is privileged to have a champion such as Dr. Mitchell, who is a widely respected clinician as well as decorated military veteran. Her service to both our country and our field is laudable." Dr. Mitchell is board certified in internal medicine and medical oncology and serves as a clinical professor of Medicine and Medical Oncology at the Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia. She also serves as the associate director for diversity programs and director of the Center to Eliminate Cancer Disparities for the Sidney Kimmel Cancer Center at Jefferson. Additionally, Dr. Mitchell served as the 116th president of the National Medical Association. Her work on chemoradiation for gastrointestinal cancers has helped raise the profile of radiation oncology by providing clinical evidence for the merits of combined modality treatment. Through the NRG Oncology/Radiation Therapy Oncology Group (RTOG), she has provided medical oncology leadership for prospective chemoradiation trials defining standards of care for gastrointestinal malignancies. As a result, Dr. Mitchell has authored several peer-reviewed publications on the RTOG trials 0012 and 0247. "The RTOG trials helped break new ground for radiation oncology," says ASTRO Immediate Past Chair Bruce D. Minsky, MD, FASTRO, who nominated Dr. Mitchell for this award. "Edith is a strong advocate and friend of radiation oncology. I can think of no other medical oncologist who has made more significant positive contributions to our community." She has also had leadership positions in trials examining breast, colon and pancreatic cancers involving new drug evaluation and chemotherapy, development of new therapeutic regimens, patient selection criteria and supportive care for patients with gastrointestinal cancer. Dr. Mitchell graduated from Tennessee State University in Nashville with a Bachelor of Science in biochemistry. She went on to the Medical College of Virginia, in Richmond, and completed her internship and residency at Meharry Medical College followed by a fellowship in medical oncology at Georgetown University. Dr. Mitchell received a commission through the Health Professions Scholarship Program in 1973 to join the Air Force while in medical school. She entered active duty after completing her fellowship at Georgetown. Dr. Mitchell is now a retired brigadier general, the first female physician to attain this rank in the history of the U.S. Air Force. Over her military career, she has been awarded more than 15 service medals and ribbons, including the Legion of Merit, Meritorious Service Medal and Humanitarian Service Medal, among others. In her medical career, Dr. Mitchell has authored or co-authored more than 130 articles, book chapters and abstracts on cancer treatment, prevention and cancer control. She has served on several National Cancer Institute review panels, including the Clinical Trials and Translational Research Advisory Committee and the Blue Ribbon Panel convened to advise the National Cancer Advisory Board on former Vice President Biden's National Cancer Moonshot Initiative. She was awarded the American Cancer Society's Cancer Control Award for her significant commitment to research, education and diversity. Dr. Mitchell says she is honored to receive the 2017 ASTRO Honorary Membership and looks forward to further research on combined modality therapeutic interventions. For more information about ASTRO's 59th Annual Meeting, visit http://www. . For press registration and news briefing information for ASTRO's 59th Annual Meeting, visit http://www. . For media inquiries, contact Liz Gardner, Media Relations Manager, Leah Kerkman Fogarty, Communications Manager. ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes three medical journals, International Journal of Radiation Oncology * Biology * Physics, Practical Radiation Oncology and Advances in Radiation Oncology; developed and maintains an extensive patient website, RT Answers; and created the Radiation Oncology Institute, a nonprofit foundation to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment. To learn more about ASTRO, visit http://www. .


News Article | June 1, 2017
Site: www.prlog.org

Nissan partners with Meharry Medical College on educational visit for residents in Preventive and Occupational Medicine - Mathews Nissan Is Proud to Be A Part Of The Nissan Brand & Educational Partnership.. visit us online.....


News Article | August 7, 2017
Site: www.businesswire.com

MINNEAPOLIS--(BUSINESS WIRE)--The board of directors of UnitedHealth Group (NYSE: UNH) announced Valerie Montgomery Rice, M.D., and Sir Andrew Witty have joined the board. Richard Burke, chairman of the board of directors of UnitedHealth Group, said, “ Valerie Montgomery Rice and Andrew Witty both have broad firsthand experience in health systems and research and the application of modern health care data and analytics. Each is a leading thinker on the future of health care. Valerie brings us in-depth knowledge and understanding of the specific health care needs of a wide range of communities, and how to better prepare the next generation of health care leaders to address those needs. Andrew has deep experience in health technology research and access strategies, as well as extensive skills in improving care delivery through developing partnerships and sharing information. His broad international experience in health care will help us grow to serve more people in more nations around the world. We are pleased and gratified to welcome them to the board.” Montgomery Rice is the President and Dean of the Morehouse School of Medicine, a medical school in Atlanta, Georgia, and has served in that capacity since 2014 and as the EVP and Dean from 2011 to 2014. Prior to joining Morehouse School of Medicine, she served as Dean of the School of Medicine and Senior Vice President of Health Affairs at Meharry Medical College, and as the director of the Center for Women’s Health Research, one of the nation’s first research centers devoted to studying diseases that disproportionately impact women of color. Montgomery Rice also serves as a Council Member of the National Institute of Health (NIH) National Center for Advancing Translational Science. Montgomery Rice is a Member of the National Academy of Medicine and a renowned infertility specialist and women’s health researcher. She holds a bachelor’s degree in chemistry from the Georgia Institute of Technology and a medical degree from Harvard School of Medicine. Montgomery Rice completed her residency in obstetrics and gynecology at Emory University School of Medicine and her fellowship in reproductive endocrinology and infertility at Hutzel Hospital in Detroit, MI. Witty was CEO and a board member of GlaxoSmithKline plc (GSK), a global pharmaceutical company, from 2008 to April, 2017. He joined GSK in 1985 and, prior to 2008, served in various senior roles in Europe, South Africa, the U.S. and Asia. He is Chancellor of the University of Nottingham, a British public research university, serving in that capacity since January 2013. He is a Business Ambassador for the U.K. Prime Minister. Witty serves on the Singapore Economic Development Board International Advisory Committee, the Council at the London School of Hygiene and Tropical Medicine and as an Advisor to the Bill and Melinda Gates Foundation. Witty was knighted in the 2012 New Year Honours for services to the economy and the U.K. pharmaceutical industry. He also serves on the board of G1 Therapeutics, Inc. UnitedHealth Group (NYSE: UNH) is a diversified health and well-being company dedicated to helping people live healthier lives and helping make the health system work better for everyone. UnitedHealth Group offers a broad spectrum of products and services through two distinct platforms: UnitedHealthcare, which provides health care coverage and benefits services; and Optum, which provides information and technology-enabled health services. For more information, visit UnitedHealth Group at www.unitedhealthgroup.com or follow @UnitedHealthGrp on Twitter. Click here to subscribe to Mobile Alerts for UnitedHealth Group.


The International Association of HealthCare Professionals is pleased to welcome Carolyn Whitney, MD, Pediatrician to their prestigious organization with her upcoming publication in The Leading Physicians of the World. Dr. Carolyn Whitney is a highly trained and qualified physician with an extensive expertise in all facets of her work. Featuring over three decades of experience in her field, she is currently serving patients in Memphis, Tennessee. She is also affiliated with Regional One Health in Memphis. Dr. Whitney’s acclaimed career in medicine began in 1984, when she graduated from Meharry Medical College in Nashville, Tennessee. Upon earning her Medical Degree, she completed postgraduate training at Wayne State University School of Medicine in Detroit, Michigan. Dr. Whitney is certified by the American Board of Pediatrics, and is an active member of the Tennessee Medical Association. She attributes her success to her drive to make a difference, and providing quality patient care, and when she is not working Dr. Whitney enjoys traveling, reading, and watching movies. Learn more about Dr. Whitney by reading her upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit http://www.findatopdoc.com


News Article | June 6, 2017
Site: www.prnewswire.com

"I look forward to working alongside these impressive leaders," said Marion McCourt, president and chief operating officer. "We are building an executive team of forward thinking industry leaders with proven track records and decades of experience. Known for their flawless execution, these individuals will help take Axovant to our next stage of growth." Mr. Mohr joins Axovant with over 25 years of experience in pharmaceutical legal and compliance matters. He was previously U.S. General Counsel and Deputy General Counsel, North America at AstraZeneca. Prior to assuming that position, he was Global Compliance Officer for AstraZeneca. He also held a number of senior legal and compliance positions at Bristol-Myers Squibb Company, including Vice President and Senior Counsel, U.S. Medicines. Earlier in his career, he specialized in litigation matters at Weiss David Fross Zelnick & Lehrman, P.C. (now Fross Zelnick Lehrman & Zissu) and Rivkin Leff Sherman & Radler (now Rivkin Radler LLP). Mr. Mohr holds a B.A. from Yale University and a J.D. from the University of Virginia School of Law. Dr. Floyd joins Axovant with nearly 20 years of regulatory experience within the pharmaceutical industry. Most recently, he was president of compliance services and chief scientific officer at Dohmen Life Science Services, Inc. He was SVP, US Regulatory Affairs and Clinical Quality Compliance at Lundbeck Inc., Global Vice President of Regulatory Affairs at Hospira, Vice President of Worldwide Regulatory Affairs and Quality Assurance at Cephalon and VP and Global Head of Respiratory, Dermatology, and Tropical Medicines Drug Regulatory Affairs at Novartis and held senior leadership roles at Bristol Myers Squibb, Aventis and Merck Research Laboratories. Dr. Floyd holds a B.S. from the University of Illinois, an M.S. from Tennessee State University, an M.B.A. from St. Joseph's University, Philadelphia, and a Ph.D. from Meharry Medical College, Nashville. Dr. Templeman joins Axovant with over 25 years of experience across various aspects of pharmaceutical operations. He most recently served as chief operations officer at Graybug Vision, and was senior vice president of pharmaceutical operations and quality at Medivation prior to that. He previously held positions of increasing responsibility at Hospira, Inc., Liquidia Technologies, and the Johnson & Johnson companies Centocor Biologics and Ortho Clinical Diagnostics. Dr. Templeman holds a B.S. from the University of Santa Clara and a Ph.D. from Dartmouth College. Mr. Wadley joins Axovant with 24 years of commercial leadership experience across sales, marketing, payer access and commercial operations. Mr. Wadley most recently served as senior vice president of sales at Guardant Health and previously was Vice President Oncology Sales, Organized Customers, and Payer at Medivation. He has also held various roles of increasing responsibility at Amgen, Wyeth BioPharma and Genetics Institute. Mr. Wadley holds a B.S. from Arizona State University. Ms. Bari joins Axovant with over 25 years of U.S. and global communications experience in the healthcare and pharmaceutical industries. Most recently, she was vice president of corporate communications at Medivation, and was senior vice president of corporate communications at Pharmacyclics prior to that. She has also held positions of increasing responsibility at Ikaria, Johnson & Johnson and Pfizer, in addition to having held senior-level positions at several of the world's leading global communications firms. She began her career at a New York teaching hospital.  Ms. Bari holds a B.A. and M.A. from New York University. In addition, current executive team member Dr. Shankar Ramaswamy will take on a new role at Axovant as vice president, global medical affairs. Dr. Ramaswamy was one of the earliest employees of Axovant and has served the company in multiple roles, including most recently as vice president, medical and scientific communications. He was also involved in the scientific evaluation of new assets for Axovant. Dr. Ramaswamy holds an A.B. from Harvard University and a M.D. from Brown University. Mark A. Demitrack, M.D., joins Axovant as vice president, clinical research with over 25 years of academic and industry experience. Most recently, he was vice president and chief medical officer at Neuronetics. He previously held positions of increasing responsibility at Wyeth Pharmaceuticals, Lilly Research Laboratories, and University of Michigan. Dr. Demitrack holds a B.A. from Columbia University and an M.D. from the Robert Wood Johnson Medical School at the University of Medicine and Dentistry of New Jersey. Richard O'Neal, R.Ph., joins Axovant as vice president of payer, access and reimbursement with more than 20 years of experience in U.S. payer and reimbursement. Most recently, he was executive director of national accounts at Amgen. He also held positions of increasing responsibility at Express Scripts, Inc. Prior to that, he was a pharmacy manager at Walgreen's Pharmacy. He holds a B.S. from the St. Louis College of Pharmacy and an M.B.A. from Lindenwood University in Missouri. Axovant is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative medicines to broadly address multiple forms of dementia and related neurological disorders. Axovant is developing a pipeline of late- and early-stage product candidates that focuses on the cognitive, functional, and behavioral aspects of debilitating conditions such as Alzheimer's disease and Lewy body dementia and other neurological disorders. For more information, visit www.axovant.com. This press release contains forward-looking statements, including statements regarding Axovant's clinical development and regulatory strategy for intepirdine and nelotanserin. Forward-looking statements can be identified by the words "believe," "anticipate," "continue," "estimate," "project," "expect," "plan," "potential," "intend," "will," "would," "could," "should" or the negative or plural of these words or other similar expressions that are predictions or indicate future events, trends or prospects. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: risks associated with the success, cost and timing of our product development activities and clinical trials; the approval and commercialization of intepirdine and nelotanserin; and increased regulatory requirements. These statements are subject to the risk that clinical trial data are subject to differing interpretations, and regulatory agencies, medical and scientific experts and others may not share Axovant's views of the clinical study data. In addition, promising interim results or other preliminary analyses do not in any way ensure that later or final results in a clinical trial or in related or similar clinical trials will replicate those interim results. The product discussed is investigational and not approved and there can be no assurance that the clinical program for intepirdine or nelotanserin will be successful in demonstrating safety and/or efficacy, that we will not encounter problems or delays in clinical development, or that any of our product candidates will ever receive regulatory approval or be successfully commercialized. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Axovant's business in general, see the "Risk Factors" section of our quarterly report on Form 10-Q filed with the Securities and Exchange Commission on February 14, 2017, and other filings that Axovant makes with the SEC from time to time. These forward-looking statements are based on information available to Axovant as of the date of this press release and speak only as of the date of this release. Axovant disclaims any obligation to update these forward-looking statements, except as may be required by law. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/axovant-strengthens-executive-team-with-key-management-appointments-300469322.html


The International Association of HealthCare Professionals is pleased to welcome Angela Wright Brown, MD, Dentist, to their prestigious organization with her upcoming publication in The Leading Physicians of the World. Dr. Angela Wright Brown is a highly trained and qualified dentist with an extensive expertise in all facets of her work. She has been in practice for more than two decades and is currently serving patients within her own private practice, Healthy Smiles, located in Huntsville, Alabama. Dr. Brown’s career in dentistry began in 1996 when she graduated with her Doctor of Dental Surgery Degree from Meharry Medical College in Nashville, Tennessee. Following her graduation, she served as Chief Resident of Hospital Dentistry at Meharry Medical College. As a board certified dentist, Dr. Brown maintains professional memberships with several leading dental organizations, including the American Dental Association. With the support of her expert team, she provides a comprehensive range of cosmetic and general dental services. Dr. Brown attributes her success to her strong faith, and in her free time, she enjoys reading, cooking, traveling, and spending time with her family. Learn more about Dr. Brown here: http://www.healthysmileshuntsville.com/ and be sure to read her upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit http://www.findatopdoc.com


Whitty J.E.,Meharry Medical College
Clinical Obstetrics and Gynecology | Year: 2010

Women with cystic fibrosis (CF) are living to childbearing age and many have successful pregnancies. Preconception care with optimization of pulmonary function, eradication of pulmonary infection, improved nutritional status, and diabetes care improve fertility and pregnancy outcome. Women with CF, poor pulmonary function and nutrition, and less than ideal body weight are more likely to suffer adverse outcomes. Women with CF and pulmonary hypertension risk mortality. Individuals with CF and end stage lung disease have improved survival after lung transplant. Women with lung transplants can have successful pregnancy, but the risk of organ rejection and death are high. © 2010, Lippincott Williams & Wilkins.

Loading Meharry Medical College collaborators
Loading Meharry Medical College collaborators